Radient Technologies

Edmonton, Canada Founded: 2001 • Age: 25 yrs
High-value natural plant extracts are developed and marketed.
Annual revenue - Latest available
Total funding $2.5M 18 rounds
Employees - Tracked headcount
Investors 5 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Radient Technologies

Radient Technologies is a company based in Edmonton (Canada) founded in 2001. Radient Technologies has raised $2.49 million across 18 funding rounds from investors including Aurora Cannabis, Afternic and Moskowitz Capital. Radient Technologies operates in a competitive market with competitors including Laurus Labs, OmniActive, Sterling Pharma Solutions, Provepharm Life Solutions and Symbiotec, among others.

  • Headquarter Edmonton, Canada
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.49 M (USD)

    in 18 rounds

  • Latest Funding Round
    $29.78 K (USD), Post-IPO

    Apr 20, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Radient Technologies

Headcount 10-50
Employee Profiles 7
Board Members and Advisors 1
Employee Profiles
People
Steven Splinter
CEO & President
People
Prakash Hariharan
CFO

Unlock access to complete

Board Members and Advisors
people
Dimitris Tzanis
Director

Unlock access to complete

Funding Insights of Radient Technologies

Radient Technologies has successfully raised a total of $2.49M across 18 strategic funding rounds. The most recent funding activity was a Post-IPO round of $29.78 thousand completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 18
  • Last Round Post-IPO — $29,782
  • First Round

    (01 Jan 2003)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2023 Amount Post-IPO - Radient Technologies Valuation

investors

Jun, 2022 Amount Post-IPO - Radient Technologies Valuation

investors

Dec, 2021 Amount Post-IPO - Radient Technologies Valuation

investors

Investors in Radient Technologies

Radient Technologies has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Aurora Cannabis, Afternic and Moskowitz Capital.

All
Institutional
Investor Description Founded Year Domain Location
Mortgage loans are provided to individuals and businesses.
Founded Year Domain Location
Medical marijuana is produced and distributed by Aurora Cannabis.
Founded Year Domain Location
Advocates for Alaskan Natives via investments, shareholder benefits, and cultural connections.
Founded Year Domain Location

Investments & Acquisitions by Radient Technologies

Investments

Financial Statements - Radient Technologies

Radient Technologies Comparisons

+
Add Comparison
Available on Premium

Competitors of Radient Technologies

Radient Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, OmniActive, Sterling Pharma Solutions, Provepharm Life Solutions and Symbiotec, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical and biotechnology company
domain founded_year HQ Location
Nutritional supplements for multiple health ailments are developed.
domain founded_year HQ Location
Contract development, manufacturing, and analytical services for APIs are offered.
domain founded_year HQ Location
APIs and drug products are developed and valorized in pharmaceuticals.
domain founded_year HQ Location
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
domain founded_year HQ Location
Nutritional ingredients with demonstrated health effects are developed by Nutrileads.

Latest news on Radient Technologies

Frequently Asked Questions about Radient Technologies

Radient Technologies was founded in 2001 and raised its 1st funding round 2 years after it was founded.

Radient Technologies is headquartered in Edmonton, Canada. It is registered at Edmonton, Alberta, Canada.

Radient Technologies is a funded company, having raised a total of $2.49M across 18 funding rounds to date. The company's 1st funding round was a Post-IPO of $1.25M, raised on Jan 01, 2003.

Radient Technologies was founded in 2001 in Edmonton, Canada, and focuses on the extraction, purification, and isolation of compounds from plants. These natural ingredients are used in pharmaceutical intermediates, nutraceuticals, foods, and cosmetics. Products such as valerenic acid, flax SDG, and carnosic acid are produced through a combination of patented Microwave Assisted Processing technology and downstream purification methods. Operations center on natural substance development for various industries.

Radient Technologies's top competitors include Laurus Labs, OmniActive and Symbiotec.

Radient Technologies has 5 investors. Key investors include Aurora Cannabis, Afternic, Moskowitz Capital, Koniag, and BC Research Inc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available